Literature DB >> 24752264

Strain types and antimicrobial resistance patterns of Clostridium difficile isolates from the United States, 2011 to 2013.

Isabella A Tickler1, Richard V Goering2, Joseph D Whitmore3, Ashley N W Lynn2, David H Persing3, Fred C Tenover3.   

Abstract

We determined the PCR ribotypes and antimicrobial susceptibility patterns of 508 toxigenic Clostridium difficile isolates collected between 2011 and 2013 from 32 U.S. hospitals. Of the 29 PCR ribotypes identified, the 027 strain type was the most common (28.1%), although the rates varied by geographic region. Ribotype 014/020 isolates appear to be emerging. Clindamycin and moxifloxacin resistances (36.8% and 35.8%, respectively) were the most frequent resistance phenotypes observed. Reduced susceptibility to vancomycin was observed in 39.1% of 027 isolates.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24752264      PMCID: PMC4068552          DOI: 10.1128/AAC.02775-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  19 in total

1.  Comparison of the E test to the reference agar dilution method for antibiotic susceptibility testing of Clostridium difficile.

Authors:  I Poilane; P Cruaud; J C Torlotin; A Collignon
Journal:  Clin Microbiol Infect       Date:  2000-03       Impact factor: 8.067

2.  Clostridium difficile ribotype diversity at six health care institutions in the United States.

Authors:  Sheila Waslawski; Eugene S Lo; Sarah A Ewing; Vincent B Young; David M Aronoff; Susan E Sharp; Susan M Novak-Weekley; Arthur E Crist; W Michael Dunne; Joan Hoppe-Bauer; Michelle Johnson; Stephen M Brecher; Duane W Newton; Seth T Walk
Journal:  J Clin Microbiol       Date:  2013-04-03       Impact factor: 5.948

3.  Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin.

Authors:  T Peláez; L Alcalá; R Alonso; M Rodríguez-Créixems; J M García-Lechuz; E Bouza
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

4.  Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England.

Authors:  M H Wilcox; N Shetty; W N Fawley; M Shemko; P Coen; A Birtles; M Cairns; M D Curran; K J Dodgson; S M Green; K J Hardy; P M Hawkey; J G Magee; A D Sails; M W D Wren
Journal:  Clin Infect Dis       Date:  2012-07-11       Impact factor: 9.079

5.  Evaluation of the E test for susceptibility testing of anaerobic bacteria.

Authors:  D M Citron; M I Ostovari; A Karlsson; E J Goldstein
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

6.  Antimicrobial susceptibility of animal and human isolates of Clostridium difficile by broth microdilution.

Authors:  Tina Pirš; Jana Avberšek; Irena Zdovc; Brane Krt; Alenka Andlovic; Tatjana Lejko-Zupanc; Maja Rupnik; Matjaž Ocepek
Journal:  J Med Microbiol       Date:  2013-07-16       Impact factor: 2.472

7.  In vitro activities of 15 antimicrobial agents against 110 toxigenic clostridium difficile clinical isolates collected from 1983 to 2004.

Authors:  David W Hecht; Minerva A Galang; Susan P Sambol; James R Osmolski; Stuart Johnson; Dale N Gerding
Journal:  Antimicrob Agents Chemother       Date:  2007-05-21       Impact factor: 5.191

8.  Prevalence and distribution of Clostridium difficile PCR ribotypes in cats and dogs from animal shelters in Thuringia, Germany.

Authors:  Alexander Schneeberg; Maja Rupnik; Heinrich Neubauer; Christian Seyboldt
Journal:  Anaerobe       Date:  2012-08-24       Impact factor: 3.331

9.  Clostridium difficile in faeces from healthy dogs and dogs with diarrhea.

Authors:  Karl-Johan Wetterwik; Gunilla Trowald-Wigh; Lise-Lotte Fernström; Karel Krovacek
Journal:  Acta Vet Scand       Date:  2013-03-12       Impact factor: 1.695

10.  Relationship between bacterial strain type, host biomarkers, and mortality in Clostridium difficile infection.

Authors:  A Sarah Walker; David W Eyre; David H Wyllie; Kate E Dingle; David Griffiths; Brian Shine; Sarah Oakley; Lily O'Connor; John Finney; Alison Vaughan; Derrick W Crook; Mark H Wilcox; Tim E A Peto
Journal:  Clin Infect Dis       Date:  2013-03-05       Impact factor: 20.999

View more
  44 in total

1.  Clostridioides difficile infection in US hospitals: a national inpatient sample study.

Authors:  Daryl Ramai; Khoi Paul Dang-Ho; Chris Lewis; Paul J Fields; Andrew Ofosu; Mohamed Barakat; Ali Aamar; Emmanuel Ofori; Jonathan Lai; Gandhi Lanke; Amaninder Dhaliwal; Madhavi Reddy; James Gasperino
Journal:  Int J Colorectal Dis       Date:  2020-06-17       Impact factor: 2.571

Review 2.  Immune-based treatment and prevention of Clostridium difficile infection.

Authors:  Song Zhao; Chandrabali Ghose-Paul; Keshan Zhang; Saul Tzipori; Xingmin Sun
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

3.  Constitutive expression of the cryptic vanGCd operon promotes vancomycin resistance in Clostridioides difficile clinical isolates.

Authors:  Wan-Jou Shen; Aditi Deshpande; Kirk E Hevener; Bradley T Endres; Kevin W Garey; Kelli L Palmer; Julian G Hurdle
Journal:  J Antimicrob Chemother       Date:  2020-04-01       Impact factor: 5.790

4.  Differences in the Molecular Epidemiology and Antibiotic Susceptibility of Clostridium difficile Isolates in Pediatric and Adult Patients.

Authors:  Larry K Kociolek; Dale N Gerding; James R Osmolski; Sameer J Patel; David R Snydman; Laura A McDermott; David W Hecht
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

5.  Clostridioides difficile ribotype 106: A systematic review of the antimicrobial susceptibility, genetics, and clinical outcomes of this common worldwide strain.

Authors:  T J Carlson; D Blasingame; A J Gonzales-Luna; F Alnezary; K W Garey
Journal:  Anaerobe       Date:  2019-12-19       Impact factor: 3.331

6.  The evolving epidemiology of Clostridium difficile infection in Canadian hospitals during a postepidemic period (2009-2015).

Authors:  Kevin C Katz; George R Golding; Kelly Baekyung Choi; Linda Pelude; Kanchana R Amaratunga; Monica Taljaard; Stephanie Alexandre; Jun Chen Collet; Ian Davis; Tim Du; Gerald A Evans; Charles Frenette; Denise Gravel; Susy Hota; Pamela Kibsey; Joanne M Langley; Bonita E Lee; Camille Lemieux; Yves Longtin; Dominik Mertz; Lorraine Maze Dit Mieusement; Jessica Minion; Dorothy L Moore; Michael R Mulvey; Susan Richardson; Michelle Science; Andrew E Simor; Paula Stagg; Kathryn N Suh; Geoffrey Taylor; Alice Wong; Nisha Thampi
Journal:  CMAJ       Date:  2018-06-25       Impact factor: 8.262

Review 7.  Epidemiology of antimicrobial resistance in bloodstream infections.

Authors:  Murat Akova
Journal:  Virulence       Date:  2016-04-02       Impact factor: 5.882

8.  Clostridium difficile infection among hospitalized HIV-infected individuals: epidemiology and risk factors: results from a case-control study (2002-2013).

Authors:  Stefano Di Bella; Alexander W Friedrich; Esther García-Almodóvar; Maria Serena Gallone; Fabrizio Taglietti; Simone Topino; Vincenzo Galati; Emma Johnson; Silvia D'Arezzo; Nicola Petrosillo
Journal:  BMC Infect Dis       Date:  2015-04-22       Impact factor: 3.090

9.  A Clostridium difficile Lineage Endemic to Costa Rican Hospitals Is Multidrug Resistant by Acquisition of Chromosomal Mutations and Novel Mobile Genetic Elements.

Authors:  Gabriel Ramírez-Vargas; Carlos Quesada-Gómez; Luis Acuña-Amador; Diana López-Ureña; Tatiana Murillo; María Del Mar Gamboa-Coronado; Esteban Chaves-Olarte; Nicholas Thomson; Evelyn Rodríguez-Cavallini; César Rodríguez
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

Review 10.  Clostridium Difficile Infection from a Surgical Perspective.

Authors:  Andreas M Kaiser; Rachel Hogen; Liliana Bordeianou; Karim Alavi; Paul E Wise; Ranjan Sudan
Journal:  J Gastrointest Surg       Date:  2015-04-28       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.